Hongshan Chen
- Cancer Research top 10%
- Immunology top 10%
- interferon and immune responses 4
- Molecular Biology top 10%
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 5
- Ubiquitin and proteasome pathways 4
- RNA Research and Splicing 4
- Genomics and Chromatin Dynamics 3
- Aging top 10%
- Biochemistry top 5%
-
- Liver Disease Diagnosis and Treatment 4
-
- Hepatitis C virus research 3
- Co-authors
- Matthew J. GamblePenelope D. RuizWendy M. McKimpsonRichard N. KitsisHong JiangQuanwen YinJong Woo ParkJ. Jessica Yu
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hongshan Chen
58 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 248
- Immunology 336
- Molecular Biology 1.0k
- Aging 26
- Biochemistry 87
Countries citing papers authored by Hongshan Chen
This map shows the geographic impact of Hongshan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongshan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongshan Chen more than expected).
Fields of papers citing papers by Hongshan Chen
This network shows the impact of papers produced by Hongshan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongshan Chen. The network helps show where Hongshan Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongshan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 45 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 14 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 44 | |
| 11 | 2021 | 61 | |
| 12 | 2020 | 91 | |
| 13 | 2020 | 25 | |
| 14 | 2018 | 15 | |
| 15 | 2016 | 11 | |
| 16 | 2014 | 26 | |
| 17 | 2014 | 92 | |
| 18 | 2009 | 19 | |
| 19 | 2007 | 12 | |
| 20 | 2005 | 8 |
About Hongshan Chen
Hongshan Chen is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 60 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (5 papers), interferon and immune responses (4 papers), Ubiquitin and proteasome pathways (4 papers), Liver Disease Diagnosis and Treatment (4 papers), RNA Research and Splicing (4 papers), Genomics and Chromatin Dynamics (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Cancer Research (248 citations), Immunology (336 citations) and Molecular Biology (1.0k citations). Hongshan Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Matthew J. Gamble, Penelope D. Ruiz, Wendy M. McKimpson, Richard N. Kitsis, Hong Jiang, Quanwen Yin, Jong Woo Park, J. Jessica Yu, B. Belinda Ding and Enguang Bi. Their work appears in journals such as Advanced Materials, Circulation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.